pharma

By Laura Lovett 02:53 pm July 26, 2019
Digital health is still somewhat of an enigma to many in the traditional world of pharma, but that is rapidly changing. As the use cases for digital tools continues to evolve, the life science world is starting to make a concerted effort to engage the new technologies.  This growing digital health ecosystem is now a major conversation point at MassBio, an organization dedicated to advancing the...

Credit: Flow

By Leontina Postelnicu 07:49 am July 24, 2019
Malmö-based medical device startup Flow has landed $1.5m (approximately €1.35m) in funding in a round led by Khosla Ventures, it was announced this week. The new funds will be used to support the European rollout of Flow's brain stimulation headset and therapy app, developed to treat depression, which were launched in the UK and Sweden earlier this year. “The Khosla Ventures investment will...
By Dave Muoio 04:13 pm July 10, 2019
Clover Health, an Alphabet-backed insurtech startup serving the Medicare Advantage market, announced this morning the launch of a new subsidiary unit that will be focused on using data from its members to drive drug development. Much like its parent company uses machine learning and artificial intelligence to generate predictive health insights for its member population, Clover Therapeutics will...
By Nathan Eddy 11:36 am July 9, 2019
Cloud-based computing could offer major benefits to pharmaceutical companies in the area of drug development as they grapple with rising costs and avalanches of data that need to be collected, analyzed and shared. In particular, the technology could help streamline operations and develop business cases as to whether a drug is likely to be needed — or financially viable. “If you’ve got big pots of...
By Nathan Eddy 03:27 pm July 3, 2019
Cloud technology opens up the potential for exciting innovations when it comes to the design and execution of clinical trials, but data security and privacy concerns are holding innovation at a snail’s pace.  Despite these misgivings, cloud-based solutions could in fact offer greater security, as well as the ability to access large pools of data that would improve an organization’s ability to...
By Laura Lovett 04:15 pm July 1, 2019
It would be hard to discuss healthcare trends without talking about what this means for the behemoth pharma industry. Recently, new kid on the block digital health has started to turn heads in across this well-established sector with its potential for improving R&D, tracking real-world evidence and even creating a new type of medicine with digital therapeutics.  While digital promises the...
By Dave Muoio 03:52 pm June 5, 2019
Healthcare is in the midst of a digital shift. Artificial intelligence offers physicians providers an new resource when making decisions, new data streams promise hyper-personalized treatments and digital therapeutics evangelists see are hawking the novel treatments as a companion, or even a replacement, to traditional biologic treatments. All in all, it’s a future that hopes to empower the...
By Joe Slavinsky 01:58 pm May 16, 2019
About the author: Joe Slavinsky leads business development efforts with pharmaceutical, biotechnology and medical technology companies in his VP position at Propeller Health. A former epidemiologist, he worked at a hedge fund (Citadel) and an investment bank (Thomas Weisel Partners) as an equity research analyst covering small/mid-cap biotechnology companies. Joe joined Propeller from Gilead...
By Tammy Lovell 05:50 am May 14, 2019
Governments, industry and regulators worldwide are trying to make the pharmaceutical supply chain more bullet-proof and the use of blockchain based track and trace technology has been hailed as a possible solution. Blockchain is an electronic cryptographic ledger which creates an immutable record of all events throughout the supply chain, allowing digital information to be distributed without...

Credit: Bayer AG

By Tammy Lovell 07:17 am May 7, 2019
Life sciences giant Bayer has joined forces with clinical AI technology company Sensyne Health to help develop a national linked patient data capability. The German firm has signed a memorandum of understanding to be the preferred pharmaceutical partner in a consortium, which includes Microsoft, EY, JP Morgan, and Peel Hunt. The consortium aims to accelerate the discovery and development of new...
steroid-pharm.com/decaver.html

www.steroid-pharm.com

bestseller.reviews/do-you-want-a-coffee-maker-with-grinder-lets-choose-it/